Pathology Doctors in New London, CT Accepting Medicare

8 Pathology doctors found. Showing 1 - 8

Nicole Muscato, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Asim Ejaz, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Kevin B Green, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Dr. Anica Antic, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Dr. Maria Victoria G Reyes, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Dr. Elise Lindsay Krejci, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Dr. Joseph C Benedict, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

Dr. Joseph A Cox, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-5100    Fax: 860-444-3709

News Archive

Protalix BioTherapeutics submits validation data for taliglucerase alfa manufacturing process to the FDA

Protalix BioTherapeutics, Inc., announced today it has submitted validation data regarding the Company's manufacturing process for taliglucerase alfa to the U.S. Food and Drug Administration (FDA). The Company made the submission in response to a request from the FDA for validation data from the Company's upgraded manufacturing facility. The FDA is currently reviewing the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease.

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

In follow-up coverage to the WHO's report on women's health, several news outlets examine the impact HIV/AIDS is having on women around the world. "In its first study of women's health, the World Health Organization said yesterday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44," the Associated Press/Boston Globe reports (11/10).

Budget Request for FY 2011: Veterans laud Administration's proposed funding increases and benefits

The coauthors of The Independent Budget (IB)—AMVETS, Disabled American Veterans, Paralyzed Veterans of America and Veterans of Foreign Wars who collectively represent millions of veterans—are applauding the Administration's recently released Budget Request for FY 2011. The budget request includes significant funding increases for Department of Veterans Affairs (VA) health care and benefits, and for the first time, advance appropriation recommendations for the VA FY 2012 budget.

Predictors of early death after traumatic bleeding uncovered

The strongest predictors of early death after traumatic postinjury bleeding are Glasgow coma score, age, and systolic blood pressure, report researchers.

Read more Medical News

› Verified 6 days ago